Joseph W. Frank
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joseph W. Frank has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Gordon
Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
1 shared publication - Alan Taylor Kelley
Division of General Internal Medicine, University of Utah , Salt Lake City, UT
1 shared publication - Allison M. Gustavson
Center for Care Delivery and Outcomes Research, Minneapolis Veterans Affairs Health Care System , Minneapolis, MN 55417
1 shared publication Amy S. B. Bohnert
University of Michigan Medical School, Ann Arbor, USA
1 shared publication- Andrew W. Roberts
Department of Population Health University of Kansas Medical Center Kansas City Kansas USA
1 shared publication - Anissa Danner
Center of Innovation for Veteran‐Centered and Value‐Driven Care Veterans Affairs (VA) Puget Sound Health Care System Seattle Washington USA
1 shared publication
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature in Implementation Science Communications
- Vol. 7 (1)
Enhancing veteran care through relational facilitation: strategies and mixed methods outcomes
Background: Veterans receiving care in Veterans Health Administration (VA) and non-VA settings often face fragmented care coordination, leading to adverse outcomes. Our study aimed to enhance Veteran care coordination through three evidence-based interventions. Relational Coordination (RC) theory emphasizes enhancing communication and relationships to strengthen team dynamics, which improves care quality. This study evaluated whether RC guided facilitation (relational facilitation) enhanced collaboration and coordinated care within and between teams during intervention implementation. Methods: From 2021 to 2025 trained facilitators supported intervention implementation across 15 VAs using relational facilitation. Key activities included team role identification, relational map development, RC Survey deployment, and RC-related SMART (specific, measurable, attainable, relevant, time-based) goal setting. Relational facilitation impact was assessed using mixed methods incorporating survey data and participant interviews. Results: Nine sites ( n = 138/1017 participants) completed pre/post surveys, with 8.3% average increase post-implementation for most sites ( n = 7/9). Participants reported relational facilitation strengthened team dynamics and improved care coordination. Conclusion: Relational facilitation enhanced teams’ collaboration and intervention implementation. Relational facilitation can improve collaboration and patient outcomes.
- 6 August 2026
- Published by Springer Nature in Implementation Science Communications
- Vol. 7 (1)
Open AccessEnhancing veteran care through relational facilitation: strategies and mixed methods outcomes
Background: Veterans receiving care in Veterans Health Administration (VA) and non-VA settings often face fragmented care coordination, leading to adverse outcomes. Our study aimed to enhance Veteran care coordination through three evidence-based interventions. Relational Coordination (RC) theory emphasizes enhancing communication and relationships to strengthen team dynamics, which improves care quality. This study evaluated whether RC guided facilitation (relational facilitation) enhanced collaboration and coordinated care within and between teams during intervention implementation. Methods: From 2021 to 2025 trained facilitators supported intervention implementation across 15 VAs using relational facilitation. Key activities included team role identification, relational map development, RC Survey deployment, and RC-related SMART (specific, measurable, attainable, relevant, time-based) goal setting. Relational facilitation impact was assessed using mixed methods incorporating survey data and participant interviews. Results: Nine sites ( n = 138/1017 participants) completed pre/post surveys, with 8.3% average increase post-implementation for most sites ( n = 7/9). Participants reported relational facilitation strengthened team dynamics and improved care coordination. Conclusion: Relational facilitation enhanced teams’ collaboration and intervention implementation. Relational facilitation can improve collaboration and patient outcomes.
- 20 May 2026
- Published by Elsevier in The Journal of Pain
- Vol. 45, 106322
Group-format pain reprocessing therapy in veterans with chronic back/neck pain: A pilot study with mixed methods evaluation
- 20 May 2026
- Published by Elsevier in The Journal of Pain
- Vol. 45, 106322
Group-format pain reprocessing therapy in veterans with chronic back/neck pain: A pilot study with mixed methods evaluation
- 3 February 2022
- Published by Wiley in The American Journal on Addictions
- Vol. 31 (2) , 152-158
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings
Background: In the United States, an x‐waiver credential is necessary to prescribe buprenorphine medication treatment for opioid use disorder (B‐MOUD). Historically, this process has required certified training, which could be a barrier to obtaining an x‐waiver and subsequently prescribing. To address this barrier, the US recently removed the training requirement for some clinicians. We sought to determine if clinicians who attended x‐waiver training went on to obtain an x‐waiver and prescribe B‐MOUD, and to examine what facilitated or impeded B‐MOUD prescribing.Methods: In September 2020, we conducted a cross‐sectional, electronic survey of attendees of 15 in‐person x‐waiver pieces of training from June 2018 to January 2020 within the Veterans Health Administration (VHA). Of the attendees (n = 321), we surveyed current VHA clinicians who recalled taking the training. The survey assessed whether clinicians obtained the x‐waiver, had prescribed B‐MOUD, and barriers or facilitators that influenced B‐MOUD prescribing.Results: Of 251 eligible participants, 62 (24.7%) responded to the survey, including 27 (43.5%) physicians, 16 (25.8%) advanced practice clinicians, and 12 (19.4%) pharmacists. Of the 43 clinicians who could prescribe, 29 (67.4%) had obtained their x‐waiver and 16 (37.2%) had reported prescribing B‐MOUD. Prominent barriers to prescribing B‐MOUD included a lack of supporting clinical staff and competing demands on time. The primary facilitator to prescribing was leadership support.Conclusion and Scientific Significance: Nine months after x‐waiver training, two‐thirds of clinicians with prescribing credentials had obtained their x‐waiver and one‐third were prescribing B‐MOUD. Removing the x‐waiver training may not have the intended policy effect as other barriers to B‐MOUD prescribing persist.
- 3 February 2022
- Published by Wiley in The American Journal on Addictions
- Vol. 31 (2) , 152-158
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings
Background: In the United States, an x‐waiver credential is necessary to prescribe buprenorphine medication treatment for opioid use disorder (B‐MOUD). Historically, this process has required certified training, which could be a barrier to obtaining an x‐waiver and subsequently prescribing. To address this barrier, the US recently removed the training requirement for some clinicians. We sought to determine if clinicians who attended x‐waiver training went on to obtain an x‐waiver and prescribe B‐MOUD, and to examine what facilitated or impeded B‐MOUD prescribing.Methods: In September 2020, we conducted a cross‐sectional, electronic survey of attendees of 15 in‐person x‐waiver pieces of training from June 2018 to January 2020 within the Veterans Health Administration (VHA). Of the attendees (n = 321), we surveyed current VHA clinicians who recalled taking the training. The survey assessed whether clinicians obtained the x‐waiver, had prescribed B‐MOUD, and barriers or facilitators that influenced B‐MOUD prescribing.Results: Of 251 eligible participants, 62 (24.7%) responded to the survey, including 27 (43.5%) physicians, 16 (25.8%) advanced practice clinicians, and 12 (19.4%) pharmacists. Of the 43 clinicians who could prescribe, 29 (67.4%) had obtained their x‐waiver and 16 (37.2%) had reported prescribing B‐MOUD. Prominent barriers to prescribing B‐MOUD included a lack of supporting clinical staff and competing demands on time. The primary facilitator to prescribing was leadership support.Conclusion and Scientific Significance: Nine months after x‐waiver training, two‐thirds of clinicians with prescribing credentials had obtained their x‐waiver and one‐third were prescribing B‐MOUD. Removing the x‐waiver training may not have the intended policy effect as other barriers to B‐MOUD prescribing persist.
- 28 August 2021
- Published by Wiley in Health Services Research
- Vol. 56 (6) , 1233-1244
Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use
Objective: To estimate differences in average annual health care expenditures of adult women with chronic overlapping pain conditions (COPCs) by pain treatment modality as follows: (1) no long‐term opioid or complementary and integrative health (CIH) use; (2) CIH only use; (3) long‐term opioid only use; and (4) long‐term opioid and CIH use.Data source: Cross‐sectional Medical Expenditure Panel Survey data (2012–2016).Study design: We estimated differences between average annual expenditures of adult women with COPCs by their use of long‐term opioids and CIH modalities. Generalized linear regression with a log link function was used to estimate adjusted marginal effects in annual expenditures. The distribution family was chosen based on Modified Park Tests. We controlled for pain severity, patient demographic characteristics, physical limitations, comorbidities, mental health, insurance status, physical therapy use, and census region. We also employed propensity‐score based marginal mean weighting through stratification to balance our treatment groups on observed covariates.Data collection/extraction methods: We identified adult women (>17 years) with one or more self‐reported COPC using 3‐digit International Classification of Diseases (ICD)‐9/10‐Clinical Modification (CM) codes (N = 9169) and categorized their use of CIH and long‐term opioids.Principal findings: Compared to women without long‐term opioid or CIH use, CIH only use was significantly associated with lower inpatient expenditures (−$947 [−$1699, −$196]; p‐value < 0.01), higher office‐based expenditures ($1345 [$944, $1746]; p‐value < 0.001), and higher patient out‐of‐pocket expenditures ($628 [$409, $848]; p‐value < 0.001). Long‐term opioid use, alone or in combination with CIH, was significantly associated with higher expenditures (p‐value < 0.05) in total and across all utilization categories compared to women without any long‐term opioid or CIH use.Conclusions: Our results indicate that CIH treatment approaches for chronic pain have the potential to be utilized without increasing overall costs. Future research should further examine the role of CIH modalities in achieving cost‐effective pain management that reduces avoidable opioid use.
- 28 August 2021
- Published by Wiley in Health Services Research
- Vol. 56 (6) , 1233-1244
Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use
Objective: To estimate differences in average annual health care expenditures of adult women with chronic overlapping pain conditions (COPCs) by pain treatment modality as follows: (1) no long‐term opioid or complementary and integrative health (CIH) use; (2) CIH only use; (3) long‐term opioid only use; and (4) long‐term opioid and CIH use.Data source: Cross‐sectional Medical Expenditure Panel Survey data (2012–2016).Study design: We estimated differences between average annual expenditures of adult women with COPCs by their use of long‐term opioids and CIH modalities. Generalized linear regression with a log link function was used to estimate adjusted marginal effects in annual expenditures. The distribution family was chosen based on Modified Park Tests. We controlled for pain severity, patient demographic characteristics, physical limitations, comorbidities, mental health, insurance status, physical therapy use, and census region. We also employed propensity‐score based marginal mean weighting through stratification to balance our treatment groups on observed covariates.Data collection/extraction methods: We identified adult women (>17 years) with one or more self‐reported COPC using 3‐digit International Classification of Diseases (ICD)‐9/10‐Clinical Modification (CM) codes (N = 9169) and categorized their use of CIH and long‐term opioids.Principal findings: Compared to women without long‐term opioid or CIH use, CIH only use was significantly associated with lower inpatient expenditures (−$947 [−$1699, −$196]; p‐value < 0.01), higher office‐based expenditures ($1345 [$944, $1746]; p‐value < 0.001), and higher patient out‐of‐pocket expenditures ($628 [$409, $848]; p‐value < 0.001). Long‐term opioid use, alone or in combination with CIH, was significantly associated with higher expenditures (p‐value < 0.05) in total and across all utilization categories compared to women without any long‐term opioid or CIH use.Conclusions: Our results indicate that CIH treatment approaches for chronic pain have the potential to be utilized without increasing overall costs. Future research should further examine the role of CIH modalities in achieving cost‐effective pain management that reduces avoidable opioid use.
- Open Access
- 3 November 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (S3) , 983-987
Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety
Evidence-based treatment of opioid use disorder, the prevention of opioid overdose and other opioid-related harms, and safe and effective pain management are priorities for the Veterans Health Administration (VHA). The VHA Office of Health Services Research and Development hosted a State-of-the-Art Conference on “Effective Management of Pain and Addiction: Strategies to Improve Opioid Safety” on September 10–11, 2019. This conference convened a multidisciplinary group to discuss and achieve consensus on a research agenda and on implementation and policy recommendations to improve opioid safety for Veterans. Participants were organized into three workgroups: (1) managing opioid use disorder; (2) Long-term opioid therapy and opioid tapering; (3) managing co-occurring pain and substance use disorder. Here we summarize the implementation and policy recommendations of each workgroup and highlight important cross-cutting issues related to telehealth, care coordination, and stepped care model implementation.
- 3 November 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (S3) , 983-987
Open AccessImplementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety
Evidence-based treatment of opioid use disorder, the prevention of opioid overdose and other opioid-related harms, and safe and effective pain management are priorities for the Veterans Health Administration (VHA). The VHA Office of Health Services Research and Development hosted a State-of-the-Art Conference on “Effective Management of Pain and Addiction: Strategies to Improve Opioid Safety” on September 10–11, 2019. This conference convened a multidisciplinary group to discuss and achieve consensus on a research agenda and on implementation and policy recommendations to improve opioid safety for Veterans. Participants were organized into three workgroups: (1) managing opioid use disorder; (2) Long-term opioid therapy and opioid tapering; (3) managing co-occurring pain and substance use disorder. Here we summarize the implementation and policy recommendations of each workgroup and highlight important cross-cutting issues related to telehealth, care coordination, and stepped care model implementation.
- 3 November 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (S3) , 910-917
Association Between Opioid Dose Reduction Against Patients’ Wishes and Change in Pain Severity
Background There is inadequate evidence of long-term benefit from opioid medications for chronic pain and substantial evidence of potential harms. For patients, dose reduction may be beneficial when implemented voluntarily and supported by a multidisciplinary team but experts have advised against involuntary opioid reduction. Objectives To assess the prevalence of self-reported involuntary opioid reduction and to examine whether involuntary opioid reduction is associated with changes in pain severity. Design Prospective observational cohort study. Participants Primary care patients treated with long-term opioid therapy in the Veterans Health Administration (N = 290). Main Measures The primary exposure was self-reported past year involuntary opioid reduction. The primary outcome was the three-item PEG scale, which measures past-week average pain intensity and interference with enjoyment of life and general activity. Key Results Past year opioid reduction or discontinuation was reported by 63% (184/290). Similar numbers reported involuntary (88/290) and voluntary (96/290) opioid reduction. At baseline, there were no significant differences in pain severity between the groups (mean PEG, 7.08 vs. 6.73 vs. 7.07 for past year involuntary opioid reduction, past year voluntary opioid reduction, and no past year opioid reduction, respectively; P = 0.32). For the primary outcome of change in pain severity from baseline to 18 months, there were no significant differences between groups (mean PEG change, − 0.05 vs. − 0.44 vs. − 0.23 for past year involuntary opioid reduction, past year voluntary opioid reduction, and no past year opioid reduction, respectively; P = 0.28). Conclusions Self-reported past year involuntary opioid reduction was common among a national sample of veterans treated with long-term opioid therapy. Opioid dose reduction, whether involuntary or voluntary, was not associated with change in pain severity. Future studies should examine involuntary opioid reduction in different populations and trends over time and explore further patient- and provider-level factors that may impact patient experience and outcomes during opioid reduction.
- 3 November 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (S3) , 910-917
Association Between Opioid Dose Reduction Against Patients’ Wishes and Change in Pain Severity
Background There is inadequate evidence of long-term benefit from opioid medications for chronic pain and substantial evidence of potential harms. For patients, dose reduction may be beneficial when implemented voluntarily and supported by a multidisciplinary team but experts have advised against involuntary opioid reduction. Objectives To assess the prevalence of self-reported involuntary opioid reduction and to examine whether involuntary opioid reduction is associated with changes in pain severity. Design Prospective observational cohort study. Participants Primary care patients treated with long-term opioid therapy in the Veterans Health Administration (N = 290). Main Measures The primary exposure was self-reported past year involuntary opioid reduction. The primary outcome was the three-item PEG scale, which measures past-week average pain intensity and interference with enjoyment of life and general activity. Key Results Past year opioid reduction or discontinuation was reported by 63% (184/290). Similar numbers reported involuntary (88/290) and voluntary (96/290) opioid reduction. At baseline, there were no significant differences in pain severity between the groups (mean PEG, 7.08 vs. 6.73 vs. 7.07 for past year involuntary opioid reduction, past year voluntary opioid reduction, and no past year opioid reduction, respectively; P = 0.32). For the primary outcome of change in pain severity from baseline to 18 months, there were no significant differences between groups (mean PEG change, − 0.05 vs. − 0.44 vs. − 0.23 for past year involuntary opioid reduction, past year voluntary opioid reduction, and no past year opioid reduction, respectively; P = 0.28). Conclusions Self-reported past year involuntary opioid reduction was common among a national sample of veterans treated with long-term opioid therapy. Opioid dose reduction, whether involuntary or voluntary, was not associated with change in pain severity. Future studies should examine involuntary opioid reduction in different populations and trends over time and explore further patient- and provider-level factors that may impact patient experience and outcomes during opioid reduction.
- 7 July 2020
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 173 (1) , 70-71
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series
- 7 July 2020
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 173 (1) , 70-71
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series
- Open Access
- 1 June 2015
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 16 (6) , 1090-1100
Evaluation of a Telementoring Intervention for Pain Management in the Veterans Health Administration
Objective. Half of all Veterans experience chronic pain yet many face geographical barriers to specialty pain care. In 2011, the Veterans Health Adminis
- 1 June 2015
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 16 (6) , 1090-1100
Open AccessEvaluation of a Telementoring Intervention for Pain Management in the Veterans Health Administration
Objective. Half of all Veterans experience chronic pain yet many face geographical barriers to specialty pain care. In 2011, the Veterans Health Adminis